Allergan Plc (AGN.N) on Monday said it would buy Zeltiq Aesthetics Inc (ZLTQ.O) for about $2.48 billion to gain access to its flagship body contouring technology.
The Botox maker agreed to pay $56.50 per Zeltiq share, or a premium of 14.4 percent to the company’s Friday close.
(Reporting by Natalie Grover in Bengaluru; Editing by Shounak Dasgupta)
‘);
$(‘.second-article-divide’).append($(‘.slider.slider-module’));
$(‘.third-article-divide’).append(”);
var median = (relatedItemsTotal / 2);
var $relatedContentGroupOne = $(‘.related-content.group-one ul’);
var $relatedContentGroupTwo = $(‘.related-content.group-two ul’);
$.each($relatedItems, function(k,v) {
if (k + 1
